Date published: 2025-12-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

DUXBL Inhibitors

DUXBL inhibitors are chemical compounds that specifically target and inhibit the activity of DUXBL, a protein encoded by the DUXBL gene, which is part of the double homeobox (DUX) family. This family of transcription factors is involved in the regulation of gene expression, particularly in processes related to embryonic development, gene silencing, and cellular differentiation. DUXBL contains a double homeobox domain, a sequence motif that allows it to bind to DNA and regulate the transcription of specific genes. By inhibiting DUXBL, these compounds disrupt its ability to bind to DNA and modulate gene expression, thereby affecting the cellular processes it governs. Inhibiting DUXBL can provide insights into how its regulatory activity influences cellular behavior.

Researchers use DUXBL inhibitors to investigate the functional roles of this transcription factor in gene regulation and cellular differentiation. Inhibition of DUXBL allows scientists to observe how the disruption of its activity impacts gene expression networks, providing insight into the specific genes and pathways controlled by DUXBL. These inhibitors are valuable tools for studying how DUXBL influences the developmental processes that rely on precise transcriptional regulation. Furthermore, they help researchers understand the molecular mechanisms by which DUXBL and related homeobox proteins contribute to cellular identity and the maintenance of gene expression patterns. Through the use of DUXBL inhibitors, scientists gain a deeper understanding of transcription factor dynamics and how the modulation of such regulatory proteins affects broader cellular and developmental processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Doxorubicin may intercalate into DNA, obstructing the transcription machinery, thus potentially downregulating the production of DUXBL mRNA.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound could induce DNA hypomethylation at the DUXBL gene promoter, leading to a decrease in its transcriptional activity.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

By increasing histone acetylation, Trichostatin A might loosen chromatin structure, which could result in a decrease in DUXBL gene transcription.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Suberoylanilide Hydroxamic Acid may promote epigenetic changes that lead to condensed chromatin at the DUXBL locus, thereby reducing its transcription levels.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

5-Aza-2′-Deoxycytidine could lead to the demethylation of cytosine bases upstream of DUXBL, potentially causing a reduction in its expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

By binding to DNA, Actinomycin D could inhibit the elongation phase of RNA synthesis, leading to a reduction in DUXBL mRNA levels.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin A may bind selectively to the DUXBL gene promoter, hindering the binding of transcriptional activators and reducing expression.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine can intercalate into the DNA helix, potentially interfering with the DUXBL gene replication and transcription processes.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

JQ1 might competitively inhibit the recognition of acetylated histones, potentially leading to suppressed transcription of the DUXBL gene.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

MG-132 may stabilize transcriptional repressors through proteasome inhibition, leading to the downregulation of DUXBL expression.